AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	8,143	5,488	5,840	6,166	6,329	7,832
Short-Term Investments	39	-	-	64	53	42
Trading Asset Securities	-	37	20	14	16	161
Cash & Short-Term Investments	8,182	5,525	5,860	6,244	6,398	8,035
Cash Growth	65.96%	-5.72%	-6.15%	-2.41%	-20.37%	29.22%
Accounts Receivable	14,338	8,302	8,407	7,212	6,031	3,806
Other Receivables	815	4,792	3,528	2,711	2,764	1,845
Receivables	15,153	13,094	11,935	9,923	8,795	5,651
Inventory	6,593	5,288	5,424	4,699	8,983	4,024
Prepaid Expenses	-	1,737	1,617	1,329	1,512	1,735
Restricted Cash	-	129	102	162	-	-
Other Current Assets	12	54	116	236	556	99
Total Current Assets	29,940	25,827	25,054	22,593	26,244	19,544
Property, Plant & Equipment	13,783	11,647	10,502	9,449	10,171	8,917
Long-Term Investments	2,286	1,900	1,677	1,142	1,262	1,192
Goodwill	21,219	21,025	20,048	19,820	19,997	11,845
Other Intangible Assets	38,191	37,177	38,089	39,307	42,387	20,947
Long-Term Deferred Tax Assets	6,129	5,347	4,718	3,263	4,330	3,438
Other Long-Term Assets	2,908	1,112	1,031	909	972	846
Total Assets	114,456	104,035	101,119	96,483	105,363	66,729
Accounts Payable	25,028	3,640	3,267	2,550	2,824	2,350
Accrued Expenses	-	16,088	15,845	13,514	12,358	9,689
Short-Term Debt	1,713	330	515	350	411	661
Current Portion of Long-Term Debt	4,490	2,057	5,603	5,924	2,248	1,566
Current Portion of Leases	379	339	271	228	233	192
Current Income Taxes Payable	1,268	1,406	1,584	896	916	1,127
Current Unearned Revenue	-	126	149	182	1,181	1,958
Other Current Liabilities	1,176	3,880	3,308	2,649	2,423	2,764
Total Current Liabilities	34,054	27,866	30,542	26,293	22,594	20,307
Long-Term Debt	24,700	26,621	22,403	23,908	29,717	19,804
Long-Term Leases	1,379	1,113	857	725	754	489
Long-Term Unearned Revenue	-	-	7	14	26	38
Pension & Post-Retirement Benefits	1,271	1,330	1,520	1,168	2,454	3,202
Long-Term Deferred Tax Liabilities	3,604	3,305	2,844	2,944	6,206	2,918
Other Long-Term Liabilities	3,477	2,929	3,780	4,373	4,325	4,333
Total Liabilities	68,485	63,164	61,953	59,425	66,076	51,091
Common Stock	388	388	388	387	387	328
Additional Paid-In Capital	35,243	35,226	35,188	35,155	35,126	7,971
Retained Earnings	8,213	7,229	4,516	3,120	3,644	6,442
Comprehensive Income & Other	2,044	-2,057	-949	-1,625	111	881
Total Common Equity	45,888	40,786	39,143	37,037	39,268	15,622
Minority Interest	83	85	23	21	19	16
Shareholders' Equity	45,971	40,871	39,166	37,058	39,287	15,638
Total Liabilities & Equity	114,456	104,035	101,119	96,483	105,363	66,729
Total Debt	32,661	30,460	29,649	31,135	33,363	22,712
Net Cash (Debt)	-24,479	-24,935	-23,789	-24,891	-26,965	-14,677
Net Cash Per Share	-15.67	-15.95	-15.23	-15.96	-18.90	-11.18
Filing Date Shares Outstanding	1,551	1,551	1,550	1,550	1,549	1,313
Total Common Shares Outstanding	1,551	1,551	1,550	1,550	1,549	1,313
Working Capital	-4,114	-2,039	-5,488	-3,700	3,650	-763
Book Value Per Share	29.59	26.30	25.25	23.90	25.34	11.90
Tangible Book Value	-13,522	-17,416	-18,994	-22,090	-23,116	-17,170
Tangible Book Value Per Share	-8.72	-11.23	-12.25	-14.25	-14.92	-13.08
Land	-	6,580	6,469	5,440	6,377	5,851
Machinery	-	8,854	8,704	7,556	7,903	7,738
Construction In Progress	-	2,789	2,045	2,653	2,728	2,478

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.